Get started
Work

Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review

Year: 2020
Type: article
Study design: Case Report
Abstract: Key Points A source of treatment refractoriness in immune cytopenias appears to be residual CD138/38-positive lymphocyte populations. A short course of daratumumab is a novel treatment of refractory thrombocytopenia after failure of standard treatment options.
DOI: 10.1182/bloodadvances.2019001215
Authors: Yazan Migdady, Asiri Ediriwickrema, Ryan Patrick Jackson, Wendy Kadi, Ridhi Gupta, Francisco Socola, Sally Arai, Beth A. Martin
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,800
OpenAlex ID: W3009401973
FWCI: 4.262
Cites: 12
Cited by: 41
Related to: 10